Cancer Research

Prof. Dr. Clemens A. Schmitt (Member of the Board of the Berlin Cancer Society), Prof. Dr. Petra Feyer (Chairman of the Board of the Berlin Cancer Society), Dr. Matthias Leisegang (Charité), Dr. Kristina Zappel (Managing Director of the Berlin Cancer Society). Image: Konstantin Gastmann.

Curt Meyer Memorial Prize awarded to Charité scientist – Commendation for tumor immunologist Matthias Leisegang

Dr. Matthias Leisegang is the recipient of this year’s Curt Meyer Memorial Prize for his research work into analysing cancer mutations as a target in adoptive T-cell therapy. His work will allow the development of a patient-specific immunotherapy that fights cancer in a targeted way.

MDC cancer researcher Roland Schwarz awarded BBAW prize

Dr. Roland F. Schwarz of the MDC conducts research on tumors using bioinformatics. He has just been awarded the Prize of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW), donated by the Monika Kutzner Foundation for the Advancement of Cancer Research, for his outstanding work.

BIMSB boosts cancer research with new research group on “Evolutionary and Cancer Genomics” headed by Roland Schwarz

Bioinformatician Roland Schwarz has been lead investigator of the new BIMSB junior research group on “Evolutionary and Cancer Genomics” since October 2016. Schwarz wants his work, particularly in the area of cancer research, to contribute towards ensuring that diseases are diagnosed earlier and treated more effectively.

New brick in PKA Legoland adds complexity to a picture we thought we knew well

Protein Kinase A (PKA) is a protein that enjoys enough fame to be sketched by young biochemists listening to lectures about how it is regulated. The fundamental kinase is present throughout the body with a role in countless processes. It’s easy to think PKA is so well studied that we know everything about it, but scientists at the MDC have found a new layer of PKA regulation which was published this week in Nature Communications.